UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $955 | +16.2% | 83,395 | +104.3% | 0.00% | 0.0% |
| Q1 2023 | $822 | -14.2% | 40,827 | -3.4% | 0.00% | 0.0% |
| Q4 2022 | $958 | -99.9% | 42,258 | -0.6% | 0.00% | 0.0% |
| Q3 2022 | $797,000 | +19.7% | 42,508 | +18.9% | 0.00% | 0.0% |
| Q2 2022 | $666,000 | -39.8% | 35,747 | -41.6% | 0.00% | 0.0% |
| Q1 2022 | $1,107,000 | -12.8% | 61,249 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,270,000 | +36.6% | 61,232 | +110.8% | 0.00% | 0.0% |
| Q3 2021 | $930,000 | +196.2% | 29,048 | +241.1% | 0.00% | +100.0% |
| Q3 2020 | $314,000 | – | 8,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |